date,title,stock,close,volume,1_past_close,2_past_close,3_past_close,4_past_close,5_past_close,next_close,next_volume,label
2010-01-13,GlaxoSmithKline plc (GSK) Sees Little Threat To Advair From Generic Competition,GSK,0.0,0.5885300291150382,0.0019217813707761,0.0128955301515423,-0.0091616295573838,0.0033868715440004,-0.0117140458103844,0.0064734679275397,0.8722987084949492,0
2010-01-15,"Market Round-up (GM, IDC, MHP, PSO, TRI, GSK, VZ, VOD, JNJ, OCR)   ",GSK,-0.0254884105105946,-0.4629604334562673,0.0064734679275397,0.0,0.0019217813707761,0.0128955301515423,-0.0091616295573838,0.0295769694058205,-0.2829164900381518,0
2010-02-12,"Market Roundup (HA, LUV, UAUA, CHL, TSM, GSK, BP, DEO, MSFT, YHOO, GOOG, AAPL, RIMM)",GSK,0.0072779790793813,-0.5418335317675074,0.0253198106175565,-0.0099216180909049,0.0091814464137363,0.0015761033478949,-0.0111714459149295,0.0129035244903419,1.1597566737538387,0
2010-02-16,GlaxoSmithKline (GSK) Shares Rise With Upgrade,GSK,0.0129035244903419,1.1597566737538387,0.0072779790793813,0.0253198106175565,-0.0099216180909049,0.0091814464137363,0.0015761033478949,0.0028029947877574,-0.5809292023298422,2
2010-03-18,"US Stock Futures Mixed (PFE, TEVA, GSK, NKE, NVS, FDX)",GSK,0.0375659524859341,1.0629032258064517,0.0002646443097524,0.001589990149148,-0.0023794102274196,-0.0005286889880481,0.0047796396576911,-0.0165729517740411,-0.1750766825043603,1
2010-03-22,FDA Asks Doctors To Suspend Use Of GlaxoSmithKline (GSK) Rotavirus Vaccine,GSK,0.0114075924691225,-0.3336978710994459,-0.0165729517740411,0.0375659524859341,0.0002646443097524,0.001589990149148,-0.0023794102274196,-0.0007690067526983,-0.061275850749535,2
2010-05-28,"Afternoon Market Update (AAPL, AMGN, GSK)",GSK,0.0029973349444936,-0.2022266922393226,0.0315402269686764,-0.0176182465503114,-0.0003041118297916,-0.0105164003552686,-0.0015000732971286,0.0059770899583193,0.5939369062976427,0
2010-07-09,"News Summary (BA, EAD, GSK)",GSK,-0.0020051605533379,0.2449106341867366,0.0136468743867661,0.0090826702982922,0.0103614036664498,-0.0041274768764751,-0.0026461452685389,0.0080369713098515,-0.2257483370288248,0
2010-07-13,GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth ,GSK,0.0170843619290463,0.4213352425272956,0.0080369713098515,-0.0020051605533379,0.0136468743867661,0.0090826702982922,0.0103614036664498,0.0176366896438811,2.3868278554338245,0
2010-08-13,All Is Not Well In The Pharmaceutical Industry,GSK,0.0252686688147765,0.4508169755455642,0.0202963675096914,-0.0251337416010549,0.0152009371093877,0.0087620421356511,0.009956022483621,-0.0023596706618915,-0.3216553287981859,2
2010-08-13,"U.S. Probing Pharmaceutical Corruption (GSK, PFE, BMY, LLY)",GSK,0.0252686688147765,0.4508169755455642,0.0202963675096914,-0.0251337416010549,0.0152009371093877,0.0087620421356511,0.009956022483621,-0.0023596706618915,-0.3216553287981859,2
2010-09-23,Travelers Mad As Hell ,GSK,-0.0179328671821283,2.881962251460759,-0.00495617676638,0.0004958360274822,0.0128075117475099,-0.0022557564189077,-0.0032459093411661,0.0263758102547366,-0.7369515311647248,0
2011-03-23,POZEN Announces Licensing Deal with a Division of Johnson & Johnson for Migraine Treatment   ,GSK,-0.0094789945296531,0.5453566621803498,0.0044962495758322,0.012587174917815,0.0,0.0202185297556163,-0.0268541493718286,0.000266274393146,-0.0496864657725134,2
2011-03-30,A Peek Into The Market Before The Trading Starts,GSK,0.0089145992408943,-0.0322267049044864,0.008727846846203,0.0023859407961814,0.0023915517905157,0.000266274393146,-0.0094789945296531,-0.0018191937214379,0.3985936715218483,2
2011-05-06,"UPDATE: FDA Approves New Treatment for Rare Type of Pancreatic Cancer (PFE, MRK, GSK)",GSK,0.0027990759313367,-0.0651061850875833,-0.0085569402149942,0.0047873495465167,-0.0013760003098072,-0.0009157011474749,0.0025255034180828,-0.004884607400667,0.6374288398828276,2
2011-06-13,"Benzinga's Political Roundup June 13, 2011",GSK,0.0098627323017495,-0.2940579442701605,-0.0160949364424491,-0.0030674536972419,-0.0105065618338413,0.0075278289887246,-0.0025806425922831,0.0090520359416645,0.0075153574696118,0
2011-07-21,"Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",GSK,0.0230770688899217,-0.0712189395421639,0.0006999545487271,-0.0013975408749203,-0.0080868175096007,0.0133458136538149,-0.0168048329002895,-0.0031901386603866,-0.3983041921213398,2
2011-07-25,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",GSK,0.0098287000303702,1.3534354485776805,-0.0031901386603866,0.0230770688899217,0.0006999545487271,-0.0013975408749203,-0.0080868175096007,0.0160706348625827,0.710093722106516,0
2011-07-26,Earnings Roundup,GSK,0.0160706348625827,0.710093722106516,0.0098287000303702,-0.0031901386603866,0.0230770688899217,0.0006999545487271,-0.0013975408749203,-0.0131434915635126,-0.280093951849677,1
2011-07-26,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter",GSK,0.0160706348625827,0.710093722106516,0.0098287000303702,-0.0031901386603866,0.0230770688899217,0.0006999545487271,-0.0013975408749203,-0.0131434915635126,-0.280093951849677,1
2011-07-26,"Amgen Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",GSK,0.0160706348625827,0.710093722106516,0.0098287000303702,-0.0031901386603866,0.0230770688899217,0.0006999545487271,-0.0013975408749203,-0.0131434915635126,-0.280093951849677,1
2011-07-28,Pfizer Earnings Preview: Analysts Expect Falling EPS,GSK,0.0137699575634284,-0.1032263911546129,-0.0131434915635126,0.0160706348625827,0.0098287000303702,-0.0031901386603866,0.0230770688899217,-0.0109105976088591,-0.0200437931615293,1
2011-08-22,"Goldman Sachs CEO Shows Signs of Fear, Hires High-Profile Defense Attorney",GSK,0.0164137376636768,0.4033373542420586,-0.0111433365075354,-0.021801048552602,0.008363201512616,-0.0061745972323998,0.0196127663426324,0.044348232342626,-0.312469556746225,0
2011-10-14,"Abbott Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",GSK,-0.0038807954139272,-0.3614519427402862,0.0094473205193856,0.0013844802616436,-0.0093714232961433,0.0202892627503932,0.0120368370704004,-0.0093952853844355,-0.1836269015212169,1
2011-10-14,"Johnson & Johnson Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",GSK,-0.0038807954139272,-0.3614519427402862,0.0094473205193856,0.0013844802616436,-0.0093714232961433,0.0202892627503932,0.0120368370704004,-0.0093952853844355,-0.1836269015212169,1
2011-10-19,Human Genome Sciences Spokesperson Comments on Recent Rumors,GSK,-0.0016128864758966,-0.1402493321460374,0.0039327842311684,-0.0093952853844355,-0.0038807954139272,0.0094473205193856,0.0013844802616436,0.0147699598945121,0.2138788192646297,0
2011-10-24,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",GSK,-0.0062220026186791,-0.1359390920412091,0.0234254072000819,0.0147699598945121,-0.0016128864758966,0.0039327842311684,-0.0093952853844355,-0.015876855267313,0.0036031314487863,1
2011-10-25,"Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",GSK,-0.015876855267313,0.0036031314487863,-0.0062220026186791,0.0234254072000819,0.0147699598945121,-0.0016128864758966,0.0039327842311684,0.0186325162228633,0.1488299226476059,0
2011-10-27,"Pfizer Earnings Preview: Analysts Expect Higher EPS, Revenue",GSK,-0.0017849567804781,0.1038097673229352,0.0186325162228633,-0.015876855267313,-0.0062220026186791,0.0234254072000819,0.0147699598945121,0.0040224949290377,-0.3897768512084009,2
2012-01-06,"Benzinga's M&A Chatter for Friday January 6, 2012",GSK,0.001084410556625,-0.1755732423725601,-0.0047468366210021,0.0015125229383654,0.014245077155667,-0.001094564148182,0.0086108112621834,-0.0394110460619963,1.568382944489139,1
2012-01-17,Taking a Closer Look at Investing in Singapore,GSK,0.0097438751260168,-0.4052181663493093,-0.0103159949615636,0.0038272367852236,0.0157788639164322,-0.0142024376906269,-0.0394110460619963,0.0210950944552827,0.598392480076289,0
2012-01-25,"Benzinga's M&A Chatter for Wednesday January 25, 2012",GSK,0.0098719727207117,-0.0307229921522791,-0.008012566973632,0.0015608625634822,0.0040284694364729,-0.0180223182433711,0.0210950944552827,0.0097756228794332,0.335630203847258,0
2012-02-09,"Benzinga's M&A Chatter for Thursday February 9, 2012",GSK,0.0160092344748852,0.0356059561560733,-0.0100445832845841,-0.0064316954539704,0.0053511380439279,0.0101349158997361,-0.0172640943680573,-0.0068800561535965,-0.1684140455982692,1
2012-03-08,"Benzinga's M&A Chatter for Wednesday March 7, 2012",GSK,0.0029176712172491,0.2388038447846208,0.0108922029946274,-0.0151959549129859,0.0117569625124827,-0.0188550593739141,0.0173773416073912,-0.0020140498919265,-0.0745445140525317,2
2012-03-21,"Benzinga's M&A Chatter for Wednesday March 21, 2012",GSK,-0.0024167965199083,0.3191670933606416,0.0004395971734691,0.0068614835845302,0.0037766488229984,-0.0004440125461195,-0.0094590640376391,-0.0026432589954988,-0.0760124207530081,2
2012-04-30,FDA Considering Letting Patients Purchase Drugs Without Prescriptions,GSK,-0.0060204833243984,-0.361528892909646,0.0067101439443804,0.0043478978224491,-0.0256306136000158,0.0004238325882097,-0.002114610090016,0.0075714978414473,-0.2249970480576218,0
2012-05-11,The Shorts Report: 10 Mega-Caps With Increased Short Selling,GSK,0.002636822902152,0.168300792906471,0.0,-0.011320670979608,0.0,0.010633182128207,-0.0174832917006,-0.0006573252981505,0.7288185068963,2
2012-06-14,Johnson & Johnson to Complete Synthes Acquisition ,GSK,0.0053255233087201,-0.3230160081743869,-0.0052973123483355,0.0204955268830437,-0.0049304170653783,0.0079060794189924,-0.0024786907587702,-0.0052973123483355,0.6932268410791773,1
2012-06-28,Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,GSK,-0.0118576383451184,0.5043401996941621,-0.0117190415005395,0.0047973233641409,-0.0006536765566954,0.0048175770925238,-0.0084677387404735,0.0126666828376071,-0.655669332536064,0
2012-07-16,Benzinga's Top Pre-Market Gainers,GSK,0.0066669414734474,0.0495872198992173,0.0119178162641757,-0.0234954402691209,0.012224596057845,-0.0343418722915621,0.007133509842893,0.0030902449992415,-0.1237550436692374,2
2012-08-06,Teva Pharmaceutical Subpoenaed By SEC in Bribery Charge,GSK,0.0117821628637038,0.7937739270602457,0.0084252325439841,0.0012979555877707,0.0049997783586148,-0.0008687775697427,0.0069993804367407,-0.0012703322097024,-0.2311148553777029,2
2012-12-11,"Benzinga's M&A Chatter for Tuesday December 11, 2012",GSK,0.0090972443613055,0.6205014544950824,0.0150046954699722,-0.0032214562346905,-0.0013788276670292,-0.0018346644613538,0.0069284893847541,-0.0036061658509468,0.1974458045544689,2
2013-01-07,4 Health Care ETFs Your Broker Forgot to Mention,GSK,0.0002257287204192,-0.0315339679792298,0.006366883413688,-0.0033992361820827,0.015183202960471,0.0055516307400615,-0.0057502368201893,0.0,-0.168891371125384,2
2013-03-04,The News of an HIV Cure Is Great News For These Publicly-Traded Companies,GSK,0.0020351553553816,0.0328144877647234,0.0043155488646915,-0.0054215089693435,0.0018103441874388,-0.0013559715858847,-0.0197162655449126,0.0067704602550924,-0.1141542585950802,0
2013-03-04,An HIV Cure Is Great News For These Publicly-Traded Companies,GSK,0.0020351553553816,0.0328144877647234,0.0043155488646915,-0.0054215089693435,0.0018103441874388,-0.0013559715858847,-0.0197162655449126,0.0067704602550924,-0.1141542585950802,0
2013-03-04,An HIV Cure Is Great News For These Drug Manufacturers,GSK,0.0020351553553816,0.0328144877647234,0.0043155488646915,-0.0054215089693435,0.0018103441874388,-0.0013559715858847,-0.0197162655449126,0.0067704602550924,-0.1141542585950802,0
2013-03-26,13 Drugs Pending FDA Approval in 2013,GSK,-0.0073365960482532,0.618827077387043,-0.0021535177529264,0.0091263133611558,0.0026143852234703,0.0030591774444541,0.0141848128300456,0.008260829579783,-0.0210578842315368,0
2013-03-26,14 Drugs Pending FDA Approval in 2013 [DRAFT],GSK,-0.0073365960482532,0.618827077387043,-0.0021535177529264,0.0091263133611558,0.0026143852234703,0.0030591774444541,0.0141848128300456,0.008260829579783,-0.0210578842315368,0
2013-03-26,15 Drugs Pending FDA Approval in 2013,GSK,-0.0073365960482532,0.618827077387043,-0.0021535177529264,0.0091263133611558,0.0026143852234703,0.0030591774444541,0.0141848128300456,0.008260829579783,-0.0210578842315368,0
2013-03-26,16 Drugs Pending FDA Approval in 2013,GSK,-0.0073365960482532,0.618827077387043,-0.0021535177529264,0.0091263133611558,0.0026143852234703,0.0030591774444541,0.0141848128300456,0.008260829579783,-0.0210578842315368,0
2013-04-02,"Benzinga's M&A Chatter for Tuesday April 2, 2013",GSK,0.0017059646878687,0.4693643180436397,-0.0004264293183118,0.0114272899874341,0.008260829579783,-0.0073365960482532,-0.0021535177529264,0.0,-0.2752517125649395,2
2013-04-11,Likely Winners and Losers in Obama's 2014 Budget,GSK,0.0161253462823167,0.6688830658368818,0.0090875722321908,0.005310949149162,0.005984290969776,-0.0040443578978377,0.0002130793312637,-0.0010306324737678,-0.2405840905968479,2
2013-04-17,Intel Expands Its Pharmaceutical R&D ,GSK,0.0194407859418992,1.9071128176997625,0.0030469784386428,0.0156801297079995,-0.0010306324737678,0.0161253462823167,0.0090875722321908,0.0009933708599667,-0.1336310459777344,2
2013-09-19,Write A Prescription For Health Care ETFs,GSK,-0.0195046470619989,0.3036079522212223,0.0027379422099045,-0.0033138503255726,-0.0021394236393205,0.0037095007947789,-0.0017542948867348,0.0051719000840488,-0.268262834191038,0
2013-11-12,Gilead Sciences Leads In Rising Short Interest Among Biotechs ,GSK,-0.0160288906321212,0.3216973786659745,-0.0024453370680902,0.0083458250061321,-0.0114378407739017,-0.0065203744986278,0.0059969018858938,0.0072919815115728,-0.2851579119620356,0
2013-11-18,13F roundup ,GSK,-0.0013440550254227,-0.245610453246223,-0.0009591014754907,0.003658085546186,0.0072919815115728,-0.0160288906321212,-0.0024453370680902,0.0113441547646018,0.5692828146143436,0
2013-11-18,2013 3Q 13F Roundup,GSK,-0.0013440550254227,-0.245610453246223,-0.0009591014754907,0.003658085546186,0.0072919815115728,-0.0160288906321212,-0.0024453370680902,0.0113441547646018,0.5692828146143436,0
2013-12-17,Market Wrap For December 17: Markets Relatively Calm Before The Potential Storm,GSK,-0.0161880169854583,0.2366442227355383,0.0101226750100726,0.0015597309747672,-0.0027221444072954,-0.0113419134975134,-0.0093315179333166,0.005680521627196,0.9253239011207376,0
2013-12-18,Merck Collaborates with GlaxoSmithKline on MK-3475,GSK,0.005680521627196,0.9253239011207376,-0.0161880169854583,0.0101226750100726,0.0015597309747672,-0.0027221444072954,-0.0113419134975134,0.0044798522404503,-0.3986582722675198,2
2014-01-07,Market Wrap For January 7: Markets Reverse Three Day Slump,GSK,0.0013209003538603,-0.1724095646842428,0.0037878417340038,0.0001891980525214,-0.0112376025515443,0.0050825882517775,0.0022641993265639,-0.0064070032391482,0.2953030078530152,1
2014-01-07,Market Wrap For January 7: Markets Reverse 3-Day Slump,GSK,0.0013209003538603,-0.1724095646842428,0.0037878417340038,0.0001891980525214,-0.0112376025515443,0.0050825882517775,0.0022641993265639,-0.0064070032391482,0.2953030078530152,1
2014-01-31,Benzinga Weekly Preview:  Twitter To Release Earnings For The First Time Since Going Public,GSK,-0.008083015720631,0.0441770186335404,-0.0015376702913943,-0.0229063993363478,0.002824269596358,-0.0041248801334337,-0.0285976091562223,-0.0104769200296463,0.2384935682950404,1
2014-01-31,Benzinga Weekly Preview: Twitter To Release Earnings For The First Time Since Going Public,GSK,-0.008083015720631,0.0441770186335404,-0.0015376702913943,-0.0229063993363478,0.002824269596358,-0.0041248801334337,-0.0285976091562223,-0.0104769200296463,0.2384935682950404,1
2014-02-03,Market Wrap For January 3: Bears In Complete and Absolute Control,GSK,-0.0104769200296463,0.2384935682950404,-0.008083015720631,-0.0015376702913943,-0.0229063993363478,0.002824269596358,-0.0041248801334337,-0.0019610086110991,-0.3123105094107405,2
2014-02-03,Market Wrap For February 3: Bears In Complete and Absolute Control,GSK,-0.0104769200296463,0.2384935682950404,-0.008083015720631,-0.0015376702913943,-0.0229063993363478,0.002824269596358,-0.0041248801334337,-0.0019610086110991,-0.3123105094107405,2
2014-02-18,Berkshire Hathaway Files SEC 13F,GSK,0.0137772452657629,0.7087319243604004,0.0150745618873158,0.0045609676899287,0.0118151438322882,0.0220751215404446,0.0030276014843584,-0.00357712830073,-0.1765452592520261,2
2014-02-20,Market Wrap For Febuary 20: S&P 500 Inches Closer to New Highs,GSK,0.0091541481569741,0.191153800545476,-0.00357712830073,0.0137772452657629,0.0150745618873158,0.0045609676899287,0.0118151438322882,-0.0094272872738393,-0.3772357723577235,1
2014-02-20,Market Wrap For Febuary 20: S&P 500 Inches Closer To New Highs,GSK,0.0091541481569741,0.191153800545476,-0.00357712830073,0.0137772452657629,0.0150745618873158,0.0045609676899287,0.0118151438322882,-0.0094272872738393,-0.3772357723577235,1
2014-03-10,Market Wrap For March 10: Markets Slightly Lower on Chinese Growth Concerns,GSK,0.0055826569952952,-0.1278775904057345,-0.0057295545159218,-0.0102781892567056,0.0,0.0112901110094292,-0.0025025373344366,-0.0034026966010423,-0.0281875658587987,2
2014-03-10,Market Wrap For March 10: Markets Slightly Lower On Chinese Growth Concerns,GSK,0.0055826569952952,-0.1278775904057345,-0.0057295545159218,-0.0102781892567056,0.0,0.0112901110094292,-0.0025025373344366,-0.0034026966010423,-0.0281875658587987,2
2014-03-20,Market Wrap For March 20: Investors Showing No Post-Fed Decision Hangover,GSK,-0.0126113919491499,0.5271859887596393,-0.0007308079633842,0.00366619801229,0.0059009388691086,-0.0023916007956037,-0.0112764534272365,-0.0175862311987341,0.2400616200949976,1
2014-03-20,Market Wrap For March 20: Investors Showing no Post-Fed Decision Hangover,GSK,-0.0126113919491499,0.5271859887596393,-0.0007308079633842,0.00366619801229,0.0059009388691086,-0.0023916007956037,-0.0112764534272365,-0.0175862311987341,0.2400616200949976,1
2014-04-02,Market Wrap For April 2: Markets on Four-day Winning Streak,GSK,-0.0056284413071255,0.1897041874759892,-0.0024332289990053,-0.0087199022618132,-0.0003708009300088,0.0061578382471181,-0.0055668197261974,-0.0052829466417523,-0.2804507879101007,1
2014-04-02,Market Wrap For April 2: Markets On Four-Day Winning Streak,GSK,-0.0056284413071255,0.1897041874759892,-0.0024332289990053,-0.0087199022618132,-0.0003708009300088,0.0061578382471181,-0.0055668197261974,-0.0052829466417523,-0.2804507879101007,1
2014-04-22,US Stock Futures Edge Higher Ahead Of McDonald's Earnings,GSK,0.0410395358437176,2.248381185094685,0.0116163829168445,-0.0058687354922247,0.0095563263305169,0.0092592504850597,0.0015458114204975,-0.0028934917865607,-0.576199789378667,2
2014-04-22,"Market Wrap For April 22: S&P Rises for Sixth Straight Day, Dow and Nasdaq Also Positive",GSK,0.0410395358437176,2.248381185094685,0.0116163829168445,-0.0058687354922247,0.0095563263305169,0.0092592504850597,0.0015458114204975,-0.0028934917865607,-0.576199789378667,2
2014-04-22,"Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive",GSK,0.0410395358437176,2.248381185094685,0.0116163829168445,-0.0058687354922247,0.0095563263305169,0.0092592504850597,0.0015458114204975,-0.0028934917865607,-0.576199789378667,2
2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report,GSK,0.0045037979293194,-0.1610122136185838,0.0067102688628868,-0.0028934917865607,0.0410395358437176,0.0116163829168445,-0.0058687354922247,0.0044833844310532,0.5350618458610847,2
2014-04-25,Benzinga Weekly Preview: Earnings Season Continues As Biotech and Pharmaceutical Companies Report,GSK,0.0045037979293194,-0.1610122136185838,0.0067102688628868,-0.0028934917865607,0.0410395358437176,0.0116163829168445,-0.0058687354922247,0.0044833844310532,0.5350618458610847,2
2014-04-30,"#PreMarket Primer: Wednesday, April 30: No BOJ Stimulus On The Horizon ",GSK,-0.0180885019084229,-0.0358959166543227,0.0067846301732461,0.0044833844310532,0.0045037979293194,0.0067102688628868,-0.0028934917865607,0.0005419686937944,-0.5587934036669057,2
2014-05-12,Google Celebrates Dorothy Hodgkins and Her Contributions in Chemistry,GSK,0.0027275638720731,0.9305905920759756,0.0016396018828745,-0.0099190977431619,0.0005413688454749,0.0023510398206327,0.0029023025505332,0.0068916786474335,0.5109432947099402,0
2014-06-04,"ASCO Meeting Day 2: ""Promising"" Results from JNJ's Imbruvica & Targeted Therapy",GSK,-0.0024427274058549,-0.0903400633563604,-0.0081998208484327,-0.0051905738539653,-0.0080915887391479,0.0111563552196864,-0.0214697637721881,0.0039556858911697,-0.1089200302089452,2
2014-06-04,"ASCO Meeting Day 2: ""Promising"" Results From JNJ's Imbruvica & Targeted Therapy",GSK,-0.0024427274058549,-0.0903400633563604,-0.0081998208484327,-0.0051905738539653,-0.0080915887391479,0.0111563552196864,-0.0214697637721881,0.0039556858911697,-0.1089200302089452,2
2014-06-18,"Advances In HIV, Hep C Treatments Spark Renewed Interest In Biotech Stocks",GSK,-0.0018498988917339,0.0392866209697893,-0.0062510978340613,-0.0020186099690264,0.001838331487675,0.0018416051866756,0.0055558478029515,0.0088970513947601,-0.2324274809160305,0
2014-06-18,"Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks",GSK,-0.0018498988917339,0.0392866209697893,-0.0062510978340613,-0.0020186099690264,0.001838331487675,0.0018416051866756,0.0055558478029515,0.0088970513947601,-0.2324274809160305,0
2014-07-15,Morning Market Movers ,GSK,-0.00485251734462,0.0044856311923893,-0.0024205552936241,-0.0126838847528165,0.0098388151912631,0.0095578156619229,-0.0138611537934318,-0.0001873745950556,0.5979978408087152,2
2014-07-28,Markets Little Changed Ahead Of The Federal Reserve's Policy Decision,GSK,-0.0082305102383059,-0.3563982813375677,-0.0295531867612302,0.0007995356713115,-0.0597518176182028,-0.0031839204626973,-0.0061428577400832,-0.003527068235425,-0.2198856379890862,2
2014-08-04,"Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",GSK,0.0104106454614087,-0.2649873035734,-0.0070292811947764,-0.0020633024936825,0.0091612466867838,-0.003527068235425,-0.0082305102383059,0.0030907202660834,0.1723619977469019,2
2014-08-04,"Glaxo, Sanofi, Trend Up On Potential Deal For Established Brands",GSK,0.0104106454614087,-0.2649873035734,-0.0070292811947764,-0.0020633024936825,0.0091612466867838,-0.003527068235425,-0.0082305102383059,0.0030907202660834,0.1723619977469019,2
2014-08-28,Markets Reverse Early Morning Losses But Still Lower On The Day,GSK,0.0041093937587493,-0.0233087597571552,0.0084951054951127,0.0027013135944611,0.009438259574936,-0.000419540768904,-0.0023009435202513,0.0047064835625403,-0.1145151145151145,2
2014-08-28,Markets Reverse Early Morning Losses; Still Lower On The Day,GSK,0.0041093937587493,-0.0233087597571552,0.0084951054951127,0.0027013135944611,0.009438259574936,-0.000419540768904,-0.0023009435202513,0.0047064835625403,-0.1145151145151145,2
2014-10-30,Ebola Vaccine Contenders,GSK,0.0013309085237529,0.2065584415584416,-0.000443395204161,-0.0059512023583044,-0.0091723608495003,0.009479939175655,0.0213914672421602,0.0077542649419075,-0.0437005543296916,0
2014-12-11,Market Shrugs Off Plan To Spend $300 Million On Ebola Vaccines,GSK,-0.0032193776182406,-0.659384512314123,-0.0140553982243394,-0.0318265013004971,-0.010425700656928,0.0032688544949679,-0.0175549974790424,-0.021453126378919,0.0463932954205328,1
2014-12-11,Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines,GSK,-0.0032193776182406,-0.659384512314123,-0.0140553982243394,-0.0318265013004971,-0.010425700656928,0.0032688544949679,-0.0175549974790424,-0.021453126378919,0.0463932954205328,1
2015-01-12,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2,GSK,0.0030377755125932,0.4149284192202647,-0.0090302782654303,0.0256470588895567,0.0103170486072399,-0.0054883311373711,-0.0108567247150136,-0.000466284037582,-0.3181104700492109,2
2015-01-12,Biotechs Presenting at the J.P. Morgan Healthcare Conference: Day Two,GSK,0.0030377755125932,0.4149284192202647,-0.0090302782654303,0.0256470588895567,0.0103170486072399,-0.0054883311373711,-0.0108567247150136,-0.000466284037582,-0.3181104700492109,2
2015-10-19,The 15 Largest Mergers In History,GSK,-0.005243334362697,0.2606386445096122,0.0101107011725112,0.0226489485583691,0.0127150704114913,-0.0066861365276772,0.0039777876243725,-0.0138954634297707,-0.096564915092145,1
2016-01-29,"Benzinga's M&A Chatter for Thursday January 28, 2015",GSK,0.0159938328276016,-0.2255463254003892,0.0009853699390196,-0.0056333259277907,0.0289821124241107,-0.0087436218083545,0.0253584580778545,0.0021796433836598,-0.2786461478994032,2
2016-02-29,25 Headlines Moving The Markets This Week,GSK,-0.0120080934583139,-0.032540926216117,-0.0091139445787379,0.0249091707039539,-0.0025879858381689,-0.0182926556408212,-0.0100603398213446,0.0256010695959094,0.1769652272805597,0
2016-04-05,"The Market In 5 Minutes: Tuesday, April 5, 2016",GSK,-0.0148889481497002,0.05943078169511,0.0156172027759049,-0.0051789522079092,-0.0036851626978259,0.0114309502310707,0.0174463907505078,0.0327053851931409,0.1570910526185953,0
2016-04-06,SocGen Picks New Favorites In Big Pharma,GSK,0.0327053851931409,0.1570910526185953,-0.0148889481497002,0.0156172027759049,-0.0051789522079092,-0.0036851626978259,0.0114309502310707,-0.0035985158649424,-0.1400490352840848,2
2016-05-03,The Market In 5 Minutes: Do Or Die,GSK,-0.0034649953532782,0.7003439380911436,0.0088559020496994,-0.0103782681867636,-0.0025309477271587,0.017794611228787,-0.0060505048498566,-0.0183127043797768,-0.2274910929778186,1
2016-05-03,The Market In 5 Minutes,GSK,-0.0034649953532782,0.7003439380911436,0.0088559020496994,-0.0103782681867636,-0.0025309477271587,0.017794611228787,-0.0060505048498566,-0.0183127043797768,-0.2274910929778186,1
2016-10-25,6 Big Pharma Companies Left To Report September Quarterly Figures,GSK,-0.00884938204183,1.0990595003393555,-0.0109408475584842,-0.0072411671511262,-0.001445986317058,-0.0064657528277694,0.0138383296303987,0.0004957630884767,-0.164103037861641,2
2016-10-26,"Earnings Scheduled For October 26, 2016",GSK,0.0004957630884767,-0.164103037861641,-0.00884938204183,-0.0109408475584842,-0.0072411671511262,-0.001445986317058,-0.0064657528277694,0.0019829875845938,-0.0817292637550884,2
2016-12-12,What We Know About Trump's Potential Pick To Head The FDA,GSK,0.0007938073618507,-0.4083186248177423,0.0106982146524978,-0.0042610238764917,-0.0037147711568639,0.0005311220595378,-0.000795771766528,0.0166577691053817,0.184716349770434,0
2016-12-19,Jefferies' 2017 Global Pharma Outlook,GSK,-0.0059673133579144,-0.3368888181329724,0.0110175091789148,0.0042148629835552,-0.0127436920417188,0.0166577691053817,0.0007938073618507,-0.0002612610399677,0.0475361622951804,2
2016-12-23,6 Worst Biotech Stocks Of 2016,GSK,0.0018285535416291,-0.4250270002043258,0.0039339196919334,-0.0044385033562969,-0.0002612610399677,-0.0059673133579144,0.0110175091789148,-0.0018252160363816,0.1926591532135242,2
2017-03-10,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,GSK,-0.0019304015608391,0.1548483648047889,0.007780430168665,-0.0074804351843771,-0.009086621148805,-0.0040489200250352,0.0079212826864445,0.0067684762877764,-0.171894652589854,0
2017-04-20,What Would A $5.8 Billion NIH Cut Look Like? Devastation.,GSK,-0.0031831890553993,-0.0104116014988129,-0.0106587512291113,-0.0133842733955852,0.0007170509537763,-0.0011941914704233,0.0019147845006728,0.0017197419076389,-0.0648322108853368,2
2017-05-23,"Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst",GSK,-0.0078520695192294,-0.0219190996670889,-0.0068808304446507,0.0083252668537572,0.0002316187534101,-0.0043759829326338,0.0006915894084531,-0.0002326000126678,-0.4401337389680412,2
2017-05-30,Alternative Paths To The Public Markets: Nexeon MedSystems' Form 10 IPO And Capital Consciousness,GSK,0.0173426384694292,-0.1559956483197678,0.0023491051555226,-0.0088477380169776,-0.0002326000126678,-0.0078520695192294,-0.0068808304446507,0.018889447764111,0.3750268541283748,0
2017-07-26,"Earnings Scheduled For July 26, 2017",GSK,-0.0264540086743194,0.3771015865498461,-0.0066288187228978,-0.009845244982641,-0.0025718127464408,0.0082510011041696,-0.0002358056781071,-0.0024478900295632,-0.2105364972917204,2
2017-08-01,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,GSK,0.002221345426822,-0.5410463872045654,-0.0100173659158699,0.0044172395010375,-0.0024478900295632,-0.0264540086743194,-0.0066288187228978,0.0034474120192835,-0.2574034685863874,2
2017-09-01,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,GSK,-0.0007455172794692,0.0057492644323446,0.0123297685311092,0.0106817370084313,-0.0035477344500931,-0.0002534182455526,0.0002534824826387,-0.0077115543053741,0.3187733279531928,1
2017-09-28,"Biotech Investors, Here's Your PDUFA Primer For October",GSK,-0.0002474590281489,0.0525379934987357,-0.0004951089080809,-0.005903939393114,0.0017249086620649,0.0061991118152431,0.003733038872002,0.0054482503768578,-0.1768292682926829,0
2017-10-23,The Week Ahead: Earnings Season Starts In Earnest,GSK,-0.0053864548116847,-0.2339526744613738,-0.006326339441509,0.0021945036473307,0.0044086032042029,-0.000734330279269,-0.0036576083438385,-0.0034466677751244,-0.363398274381993,2
2017-10-25,"Earnings Scheduled For October 25, 2017",GSK,-0.0565710879217947,3.9382442346810502,-0.0034466677751244,-0.0053864548116847,-0.006326339441509,0.0021945036473307,0.0044086032042029,-0.0416340512158776,-0.3762467428481507,1
2017-12-01,GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV,GSK,0.007415820856667,0.0290009921392047,-0.0115589793603896,-0.0125276309240853,0.0104076414660494,0.01455484205791,-0.0005705620960332,-0.0090601769345697,-0.21478899354743,1
2017-12-04,"The Week Ahead For December 4: The Biggest Catalysts, Conferences, And Investor Events",GSK,-0.0090601769345697,-0.21478899354743,0.007415820856667,-0.0115589793603896,-0.0125276309240853,0.0104076414660494,0.01455484205791,-0.003999789563125,0.4157457258902428,2
2018-01-19,Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings?,GSK,0.0007861438952792,-0.1941754320930447,0.0005238284031039,0.006065703807301,0.0111998063451606,0.0179154447161249,0.012087613466887,0.0094243674278104,0.2167275236479686,0
2018-03-23,25 Stocks Moving In Friday's Pre-Market Session,GSK,0.0351313386332523,1.6985046985389944,-0.0165941334335475,0.0,-0.0035240959115806,-0.0104611011473995,0.0097507410662303,0.0002671696242932,-0.6266283695334443,2
2018-04-25,"Earnings Scheduled For April 25, 2018",GSK,-0.0374016588004109,0.4644315229494,0.0076868331964756,0.0082498791624621,0.0030090665245829,-0.0138478744005843,-0.001727534881839,0.0276073476196025,-0.3296950240770465,0
2018-04-30,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,GSK,-0.0110947087592347,-0.5081053175012906,0.0089557047273045,0.0276073476196025,-0.0374016588004109,0.0076868331964756,0.0082498791624621,-0.0017457344918376,-0.0209487825356843,2
2018-06-08,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",GSK,0.0071201417102617,0.2257354962881494,0.0017211516491113,0.0046951439344171,-0.0056512270049667,-0.0012269996627434,0.0056763318310812,0.0041442462922696,-0.1039143113503813,2
2018-06-14,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",GSK,0.0194456532079125,0.9106023439629328,-0.0014561542525709,0.0002428487017527,0.0041442462922696,0.0071201417102617,0.0017211516491113,-0.0119215069991379,-0.3048216833095577,1
2018-07-18,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Cocktail Clears FDA Hurdle, Cara To Offer Shares",GSK,-0.0041322744370337,-0.0740362862085791,-0.0014561542525709,-0.012937224837894,-0.0002394760259939,0.0158150458323611,-0.0079651431310182,-0.0068341607462377,0.0343489508479448,1
2018-07-23,"The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs",GSK,-0.0222115786894757,-0.6849781947447502,0.0289995115286456,-0.0068341607462377,-0.0041322744370337,-0.0014561542525709,-0.012937224837894,0.0065951904528647,0.0397859469520707,0
2018-07-25,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",GSK,-0.0167436345955606,0.4185779816513761,0.0065951904528647,-0.0222115786894757,0.0289995115286456,-0.0068341607462377,-0.0041322744370337,-0.0039489359417144,-0.3043358242798273,2
2018-07-25,"Earnings Scheduled For July 25, 2018",GSK,-0.0167436345955606,0.4185779816513761,0.0065951904528647,-0.0222115786894757,0.0289995115286456,-0.0068341607462377,-0.0041322744370337,-0.0039489359417144,-0.3043358242798273,2
2018-09-04,"The Week Ahead: Mr. Dorsey Goes To Washington, Employment And Wage Data On Tap",GSK,-0.0039506973079386,-0.0669820948139902,-0.0179437045100855,-0.0084153987366039,0.0053177988021473,-0.0028923217928933,0.0050874576352417,-0.0052057685626375,-0.2607636472108978,1
2018-09-07,Benzinga Pro's 5 Stocks To Watch Today,GSK,-0.0045249185239099,-0.2076042936342547,-0.0087215062423532,-0.0052057685626375,-0.0039506973079386,-0.0179437045100855,-0.0084153987366039,-0.0075757907839237,-0.0403413883789014,1
2018-09-07,"The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Walle, Advaxis Offering",GSK,-0.0045249185239099,-0.2076042936342547,-0.0087215062423532,-0.0052057685626375,-0.0039506973079386,-0.0179437045100855,-0.0084153987366039,-0.0075757907839237,-0.0403413883789014,1
2018-11-27,GlaxoSmithKline and J&J's HIV Drug Juluca Received Approval In Japan,GSK,-0.0036983465234268,-0.2369070247098313,-0.0024594618674784,0.0037030279671053,-0.0029535801056835,-0.0048984435479295,0.0121467642678616,0.0193020926801368,1.2317027929408022,0
2018-12-19,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",GSK,0.0083582829985304,2.5015240434921067,0.000539262957014,-0.014357610493034,-0.0086981689131162,0.0069004204110736,0.0085649416738433,0.0133689008178632,-0.5626892044642509,0
2019-01-08,"TD Ameritrade IMX Continued Its Dip In December, Falling To A More Than Two-Year Low",GSK,0.0064416899753734,-0.0848563201504377,0.0049199142924978,0.0208823579824279,-0.00131954660587,-0.0086365829414036,0.0015727294538314,0.003584207185953,-0.2802286007834071,2
2019-02-06,"13 Stocks To Watch For February 6, 2019",GSK,0.0311787793209599,0.7914177587339317,0.0079203267458161,-0.0015305428644597,0.0,0.0126581179904248,-0.0002581718520477,-0.0027042741692554,-0.3585208722523875,2
2019-02-06,A Peek Into The Markets: US Stock Futures Down Ahead Of General Motors Earnings,GSK,0.0311787793209599,0.7914177587339317,0.0079203267458161,-0.0015305428644597,0.0,0.0126581179904248,-0.0002581718520477,-0.0027042741692554,-0.3585208722523875,2
2019-02-15,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",GSK,0.0093001642233636,0.0928658868335146,0.0121378566090424,-0.0039480158018013,0.0074572503653642,-0.0209294831625544,0.0128172744185066,0.0012122651150887,-0.1672734061420704,2
2019-03-29,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,GSK,-0.0019107353886973,-0.3144174447601925,0.003354671321555,0.0031251527149276,0.0094638489487945,-0.0009698393326822,0.0002423220788314,0.0004787091342246,-0.0118851245611808,2
2019-07-24,"Earnings Scheduled For July 24, 2019",GSK,0.0026621940773237,0.1205742010505632,0.0046195166657383,0.0041503592251739,-0.010867141746369,0.0065631676962987,-0.0009716642710052,0.0026550152403437,0.1281042009589923,2
2019-07-29,New Equities that Broke Through 52-Week Highs Monday Morning,GSK,0.0064421468134281,0.0698199017645988,0.0089073083125519,0.0026550152403437,0.0026621940773237,0.0046195166657383,0.0041503592251739,-0.0085347289627544,-0.1910964494626581,1
2019-08-22,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",GSK,0.0071270075156262,0.1383628272793129,0.0106805620305969,-0.0027248725298494,0.0044788221864062,0.0057557851982006,0.0070565278692977,0.005124395715337,0.5343181818181819,0
2019-08-28,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,GSK,0.0012119812376276,0.1075961356317485,-0.0007264196358179,0.0024277529221163,0.005124395715337,0.0071270075156262,0.0106805620305969,0.0099247493999408,0.4991163559660225,0
2019-09-25,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",GSK,-0.0156881538857461,-0.1848689904791879,0.0035782674012421,0.0069660807648821,0.0075023436960675,0.0063324070567303,-0.0009734035357096,0.015213771036916,0.4270959023118876,0
2019-09-27,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",GSK,0.0071361065766397,-0.1977813852813853,0.015213771036916,-0.0156881538857461,0.0035782674012421,0.0069660807648821,0.0075023436960675,0.0080301187910074,0.5532883642495785,0
2019-09-30,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,GSK,0.0080301187910074,0.5532883642495785,0.0071361065766397,0.015213771036916,-0.0156881538857461,0.0035782674012421,0.0069660807648821,-0.0086692290191502,-0.5065139507111063,1
2019-09-30,Stocks That Hit 52-Week Highs On Monday,GSK,0.0080301187910074,0.5532883642495785,0.0071361065766397,0.015213771036916,-0.0156881538857461,0.0035782674012421,0.0069660807648821,-0.0086692290191502,-0.5065139507111063,1
2019-10-01,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",GSK,-0.0086692290191502,-0.5065139507111063,0.0080301187910074,0.0071361065766397,0.015213771036916,-0.0156881538857461,0.0035782674012421,-0.0264712497228744,0.6258937410625893,1
2019-10-30,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,GSK,0.0235481385185096,0.9241698695734356,0.0042789465485486,0.0132362868989377,-0.0045434534292172,0.0173328221115272,0.0176388724985194,0.0035057059588878,-0.3208736512926305,2
2019-10-30,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",GSK,0.0235481385185096,0.9241698695734356,0.0042789465485486,0.0132362868989377,-0.0045434534292172,0.0173328221115272,0.0176388724985194,0.0035057059588878,-0.3208736512926305,2
2019-11-01,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",GSK,-0.0115720209808887,-0.330456375515321,0.0035057059588878,0.0235481385185096,0.0042789465485486,0.0132362868989377,-0.0045434534292172,-0.0053015378863588,0.0061572807143885,1
2019-12-10,Stocks That Hit 52-Week Highs On Tuesday,GSK,0.0113961439967782,-0.3705734966592428,0.002636950274315,0.0066355759714951,0.0031061279735438,0.0094065383342121,-0.0062319119067879,0.0030332446872927,-0.0684683090804546,2
2019-12-11,Stocks That Hit 52-Week Highs On Wednesday,GSK,0.0030332446872927,-0.0684683090804546,0.0113961439967782,0.002636950274315,0.0066355759714951,0.0031061279735438,0.0094065383342121,-0.0077768748951416,0.1639048478229903,1
2019-12-11,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",GSK,0.0030332446872927,-0.0684683090804546,0.0113961439967782,0.002636950274315,0.0066355759714951,0.0031061279735438,0.0094065383342121,-0.0077768748951416,0.1639048478229903,1
2019-12-12,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",GSK,-0.0077768748951416,0.1639048478229903,0.0030332446872927,0.0113961439967782,0.002636950274315,0.0066355759714951,0.0031061279735438,0.0010886089528376,-0.0217843593195447,2
2019-12-16,Stocks That Hit 52-Week Highs On Tuesday,GSK,0.019573653097076,0.6132032194837149,0.0010886089528376,-0.0077768748951416,0.0030332446872927,0.0113961439967782,0.002636950274315,-0.0051193966364081,-0.4487242457927255,1
2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",GSK,-0.0051193966364081,-0.4487242457927255,0.019573653097076,0.0010886089528376,-0.0077768748951416,0.0030332446872927,0.0113961439967782,0.0051457397190175,0.11052754982415,0
2019-12-20,Stocks That Hit 52-Week Highs On Friday,GSK,0.0065943549620439,0.4834701696770662,0.002773046249864,0.0051457397190175,-0.0051193966364081,0.019573653097076,0.0010886089528376,-0.0099324135544786,-0.2136663837951518,1
2019-12-27,Stocks That Hit 52-Week Highs On Friday,GSK,0.0081007982421534,0.8020383485921576,0.0002130662724766,0.0010673273203918,-0.0099324135544786,0.0065943549620439,0.002773046249864,-0.0044407059066901,-0.2356690950920245,2
2020-01-15,Stocks That Hit 52-Week Highs On Wednesday,GSK,0.0121170910731263,0.2426882389545737,0.0019169827434413,0.0034195593712467,0.0030008297088084,0.0051716269758119,0.0043280514373607,-0.0094515739366263,0.4049710930031411,1
2020-01-17,Stocks That Hit 52-Week Highs On Friday,GSK,0.0154792741570175,0.0649321193662313,-0.0094515739366263,0.0121170910731263,0.0019169827434413,0.0034195593712467,0.0030008297088084,-0.0081435935871873,0.1021389235403291,1
2020-01-24,Stocks That Hit 52-Week Highs On Friday,GSK,-0.0123378506078419,1.0988914994879209,0.000627669161002,0.0061051072431834,-0.0081435935871873,0.0154792741570175,-0.0094515739366263,-0.0158798663549266,-0.4857561101623158,1
2020-02-05,"Earnings Scheduled For February 5, 2020",GSK,-0.0435059594923606,2.7289151965335807,0.0083458409003036,-0.0014955107450068,-0.0038316119741276,-0.0044501157177889,0.0083335506763091,-0.0206347052238821,-0.2963116667531255,1
2020-02-27,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",GSK,-0.0073985494831338,0.8049844648641502,0.0101254191285697,-0.0104961678494862,-0.0269265554349125,0.0074837325853587,-0.003054279069753,-0.0254869478417275,1.0340792557866978,1
2020-03-02,How The COVID-19 Outbreak Is Benefiting Biotech Investors,GSK,0.0498395650015508,-0.0427721310442306,-0.0254869478417275,-0.0073985494831338,0.0101254191285697,-0.0104961678494862,-0.0269265554349125,-0.0293772527308426,-0.2006282564941782,1
2020-03-03,Pfizer Works On Compounds That May Help Stop Coronaviruses,GSK,-0.0293772527308426,-0.2006282564941782,0.0498395650015508,-0.0254869478417275,-0.0073985494831338,0.0101254191285697,-0.0104961678494862,0.0496368002548739,-0.3905687460291315,0
2020-03-10,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,GSK,0.0073674604839311,0.246727160355096,-0.0391694081950673,-0.0049308663057711,-0.0175316017407607,0.0496368002548739,-0.0293772527308426,-0.0280350956287193,-0.001306939170995,1
2020-03-12,Stocks That Hit 52-Week Lows On Thursday,GSK,-0.0842741482841815,0.1555487866788507,-0.0280350956287193,0.0073674604839311,-0.0391694081950673,-0.0049308663057711,-0.0175316017407607,0.0367022681562343,-0.1533452440226889,0
2020-03-13,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",GSK,0.0367022681562343,-0.1533452440226889,-0.0842741482841815,-0.0280350956287193,0.0073674604839311,-0.0391694081950673,-0.0049308663057711,-0.1104357423552399,0.0875095131569843,1
2020-03-16,8 Biotechs With Coronavirus Vaccines In Development,GSK,-0.1104357423552399,0.0875095131569843,0.0367022681562343,-0.0842741482841815,-0.0280350956287193,0.0073674604839311,-0.0391694081950673,0.0944459090307263,-0.3293677301693334,0
2020-03-16,Stocks That Hit 52-Week Lows On Monday,GSK,-0.1104357423552399,0.0875095131569843,0.0367022681562343,-0.0842741482841815,-0.0280350956287193,0.0073674604839311,-0.0391694081950673,0.0944459090307263,-0.3293677301693334,0
2020-03-17,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",GSK,0.0944459090307263,-0.3293677301693334,-0.1104357423552399,0.0367022681562343,-0.0842741482841815,-0.0280350956287193,0.0073674604839311,-0.0697419793026304,0.1946622818112826,1
2020-03-19,Stocks That Hit 52-Week Lows On Thursday,GSK,-0.0180863680624426,0.1990868184224457,-0.0697419793026304,0.0944459090307263,-0.1104357423552399,0.0367022681562343,-0.0842741482841815,-0.0095068967461919,-0.2259196715340551,1
2020-03-23,Stocks That Hit 52-Week Lows On Monday,GSK,-0.0446910273149343,0.0940342772407105,-0.0095068967461919,-0.0180863680624426,-0.0697419793026304,0.0944459090307263,-0.1104357423552399,0.0675037883751448,-0.0675494272048378,0
2020-03-24,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",GSK,0.0675037883751448,-0.0675494272048378,-0.0446910273149343,-0.0095068967461919,-0.0180863680624426,-0.0697419793026304,0.0944459090307263,0.0417647288451883,-0.0144941715819193,0
2020-04-14,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",GSK,0.0369801372078129,1.4499917067507049,0.0015428619385804,0.0210084539608372,0.0146551275440098,-0.0100237316015533,0.0207327280692692,-0.0138681121762304,-0.4437749644573827,1
2020-04-20,How The COVID-19 Pandemic Could End,GSK,-0.0083194107005477,-0.3161630794701987,0.0064593524528702,0.0497235109639415,-0.0138681121762304,0.0369801372078129,0.0015428619385804,-0.0124641624546607,0.0801380019973974,1
2020-04-24,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",GSK,0.0068704649713153,0.0151398582183877,0.0071580566540077,0.0172331253852269,-0.0124641624546607,-0.0083194107005477,0.0064593524528702,0.0030589301868153,-0.2895385031804033,2
2020-04-30,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",GSK,0.005256915367698,-0.2102681713935376,-0.0057021445821402,-0.0126671783297579,0.0030589301868153,0.0068704649713153,0.0071580566540077,-0.0204421632522152,-0.0646079530751315,1
2020-06-08,4 Analysts On Why The Rumored AstraZeneca-Gilead Deal Is Unlikely To Materialize,GSK,0.0160673245620686,0.9246851385390428,0.0012004966575915,-0.0111586025051078,0.0021413778338188,0.0043009672591525,-0.0016699323954609,-0.0115648604690105,-0.4508385215098995,1
2020-06-16,"The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO",GSK,0.0147345435775185,0.0563918700731314,0.007422277383464,0.005222522219253,-0.0518744457770473,0.0126551067177533,-0.0115648604690105,0.012342733104016,-0.349284124879189,0
2020-06-17,"The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked",GSK,0.012342733104016,-0.349284124879189,0.0147345435775185,0.007422277383464,0.005222522219253,-0.0518744457770473,0.0126551067177533,-0.0210374439981965,-0.3375012952920452,1
2020-06-23,"The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout",GSK,0.0089764105402603,0.0737568188990578,0.0029198116525726,0.0036628402218532,-0.0210374439981965,0.012342733104016,0.0147345435775185,-0.0221209565693235,-0.0320779275307553,1
2020-07-14,"The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits",GSK,0.0157225260909372,0.1512300572402873,0.0040089435827237,-0.0113944110955838,-0.0088388992938709,0.0086676668305287,-0.0153619350500261,0.0307124129063169,0.29610430827008,0
2020-07-15,"The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent",GSK,0.0307124129063169,0.29610430827008,0.0157225260909372,0.0040089435827237,-0.0113944110955838,-0.0088388992938709,0.0086676668305287,-0.010965148907851,-0.4394678311261656,1
2020-07-29,"Earnings Scheduled For July 29, 2020",GSK,-0.0171912833441103,0.2210132689987938,0.0102740697771417,0.0146437269635892,-0.0002481206725639,-0.0211317157391053,-0.0096223505151005,-0.0083764746631731,-0.2952322617612771,1
2020-07-29,"The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More",GSK,-0.0171912833441103,0.2210132689987938,0.0102740697771417,0.0146437269635892,-0.0002481206725639,-0.0211317157391053,-0.0096223505151005,-0.0083764746631731,-0.2952322617612771,1
2020-07-29,"GlaxoSmithKline, Sanofi Ink Deal With UK To Supply Up To 60M Doses of COVID-19 Vaccine",GSK,-0.0171912833441103,0.2210132689987938,0.0102740697771417,0.0146437269635892,-0.0002481206725639,-0.0211317157391053,-0.0096223505151005,-0.0083764746631731,-0.2952322617612771,1
2020-07-31,"The Daily Biotech Pulse: Sanofi-GSK Land $2.1M Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche",GSK,0.0017388939659295,0.4680815273767136,-0.0083764746631731,-0.0171912833441103,0.0102740697771417,0.0146437269635892,-0.0002481206725639,0.0240578279060637,-0.4385180941468538,0
2020-08-05,"J&J Clinches Coronavirus Vaccine Deal With US Government: $1B, 100M Doses",GSK,-0.0007277126886255,0.0795667474064256,-0.0012109633051503,0.0240578279060637,0.0017388939659295,-0.0083764746631731,-0.0171912833441103,-0.0058236131141663,0.2262297857929049,1
2020-08-06,GlaxoSmithKline Gets FDA Approval For Blood Cancer Drug,GSK,-0.0058236131141663,0.2262297857929049,-0.0007277126886255,-0.0012109633051503,0.0240578279060637,0.0017388939659295,-0.0083764746631731,-0.0043935607799501,0.0178485120486087,2
2020-08-06,Moderna Analyst Breaks Down Biopharma's Coronavirus Vaccine Pricing,GSK,-0.0058236131141663,0.2262297857929049,-0.0007277126886255,-0.0012109633051503,0.0240578279060637,0.0017388939659295,-0.0083764746631731,-0.0043935607799501,0.0178485120486087,2
2020-08-26,"AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FT",GSK,0.0017438608656512,-0.1146013297733102,-0.0024851000568203,0.0007461291535524,-0.0093619938388039,-0.0036817952248167,-0.0085179240168073,-0.0114400753567935,0.4790089877010406,1
2020-09-01,"Sanofi, Regeneron Rheumatoid Arthritis Drug Proves Ineffective Against COVID-19",GSK,-0.0161614906129243,0.722686345493363,0.0,-0.0037734932537504,-0.0114400753567935,0.0017438608656512,-0.0024851000568203,0.0241272128946625,-0.2341245251502007,0
2020-09-03,A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Economic Reports,GSK,-0.0223057743737603,-0.0277553030569529,0.0241272128946625,-0.0161614906129243,0.0,-0.0037734932537504,-0.0114400753567935,-0.0138425760250648,0.3643534264418553,1
2020-09-03,"Be Ready To Distribute A COVID-19 Vaccine In Two Months, CDC Tells All States",GSK,-0.0223057743737603,-0.0277553030569529,0.0241272128946625,-0.0161614906129243,0.0,-0.0037734932537504,-0.0114400753567935,-0.0138425760250648,0.3643534264418553,1
2020-09-08,AstraZeneca Shares Drop 8% As Advanced COVID-19 Vaccine Trials Are Halted,GSK,0.0129969724744225,-0.1922403733955658,-0.0138425760250648,-0.0223057743737603,0.0241272128946625,-0.0161614906129243,0.0,0.0200154195319306,0.0748875537607931,0
2020-09-08,"As Political Pressure Mounts, COVID-19 Vaccine Developers Pledge To Put Safety First",GSK,0.0129969724744225,-0.1922403733955658,-0.0138425760250648,-0.0223057743737603,0.0241272128946625,-0.0161614906129243,0.0,0.0200154195319306,0.0748875537607931,0
2020-09-09,"The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment",GSK,0.0200154195319306,0.0748875537607931,0.0129969724744225,-0.0138425760250648,-0.0223057743737603,0.0241272128946625,-0.0161614906129243,-0.0246540241667511,-0.1976175931582162,1
2020-09-17,Is AstraZeneca Still A Safe Bet?,GSK,0.0012685067558755,0.2501316230316375,0.003819616885907,0.0048617549079097,-0.0007671146406049,0.0087697279135412,-0.0246540241667511,-0.0053203890152961,0.4104291894789234,1
2020-09-30,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,GSK,0.0056103583499376,0.3038491039676452,-0.0113575006326671,0.0015872856605656,0.0112359576472378,-0.0108495678432445,-0.0055263162968826,-0.0132836836919363,0.0382918415915716,1
2020-10-06,"COVID-19 Vaccine Makers AstraZeneca, GSK To Get First Access To Nvidia's 'Cambridge-1' Supercomputer",GSK,-0.0233483979102088,0.701838696197242,0.0120838323464178,0.0026925263073118,-0.0132836836919363,0.0056103583499376,-0.0113575006326671,-0.005976732368376,-0.0796071209330877,1
2020-10-28,"Earnings Scheduled For October 28, 2020",GSK,-0.0396039489279976,0.122751211607424,0.003691149776084,-0.0019836465792019,0.0056996542364524,-0.0073550286663233,-0.0191454987466762,0.0002944632155839,-0.12304217672529,2
2020-10-28,"The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts",GSK,-0.0396039489279976,0.122751211607424,0.003691149776084,-0.0019836465792019,0.0056996542364524,-0.0073550286663233,-0.0191454987466762,0.0002944632155839,-0.12304217672529,2
2020-12-11,A Peek Into The Markets: US Stock Futures Down; Pfizer Covid-19 Vaccine Gets FDA Panel's Nod,GSK,-0.0100079022731671,0.2418048366815801,0.0034355956271334,0.005313503369059,0.0021298601774382,0.0016001497906334,0.0061710944147301,-0.0202181457733789,0.4274478406254416,1
2020-12-17,"The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut",GSK,0.0124728209573208,0.0256019330897794,0.0016295860712691,-0.0002716394439883,-0.0202181457733789,-0.0100079022731671,0.0034355956271334,-0.0088377940171409,0.6386839817126189,1
2020-12-18,"The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data",GSK,-0.0088377940171409,0.6386839817126189,0.0124728209573208,0.0016295860712691,-0.0002716394439883,-0.0202181457733789,-0.0100079022731671,-0.0213453783491422,-0.2872278515678488,1
2020-12-21,GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment,GSK,-0.0213453783491422,-0.2872278515678488,-0.0088377940171409,0.0124728209573208,0.0016295860712691,-0.0002716394439883,-0.0202181457733789,-0.003589375701697,-0.0784285474149316,2
2021-01-12,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",GSK,-0.0123914142708874,0.5234359773923212,-0.0106935917364572,0.0070921359537692,-0.006524045096744,0.0169851847610489,-0.0015900863046346,0.0058729509593429,-0.3709022291873221,0
2021-01-22,"The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",GSK,0.0153518207724625,0.2540191432023047,-0.0063124972088529,-0.0134923390927926,0.0018196409499964,0.0081235381768489,0.0127390297403642,0.0145986502699293,-0.2746118789136315,0
2021-01-27,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",GSK,-0.0270132162985471,0.2818716507646059,0.0082218519082619,0.0145986502699293,0.0153518207724625,-0.0063124972088529,-0.0134923390927926,-0.0039286249277761,-0.2470125209021575,2
2021-02-03,"The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision",GSK,-0.0577283442224335,5.808690199357249,0.0066953848341955,0.0024160477940839,-0.0205101395928407,-0.0039286249277761,-0.0270132162985471,-0.0011292711170365,-0.5193273699196819,2
2021-02-11,Merck In Talks To Possibly Produce COVID-19 Shots: WSJ,GSK,-0.0061905271637718,0.4272906853061844,-0.0058737839924447,0.0081779939700548,0.0056723394687681,-0.0033918238522434,-0.0011292711170365,0.0127408874964676,-0.2054588523368465,0
2021-02-17,Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT,GSK,0.0075733250317933,-0.0719001080674717,-0.0033546044617024,0.0127408874964676,-0.0061905271637718,-0.0058737839924447,0.0081779939700548,-0.0167742999414287,-0.042221969092911,1
2021-02-18,Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters,GSK,-0.0167742999414287,-0.042221969092911,0.0075733250317933,-0.0033546044617024,0.0127408874964676,-0.0061905271637718,-0.0058737839924447,-0.0077808486765815,-0.0290584737363726,1
2021-02-22,Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback,GSK,0.0002904124603764,-0.0660623877184386,-0.0077808486765815,-0.0167742999414287,0.0075733250317933,-0.0033546044617024,0.0127408874964676,-0.0017422116728303,0.1647139401358164,2
2021-02-23,FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants,GSK,-0.0017422116728303,0.1647139401358164,0.0002904124603764,-0.0077808486765815,-0.0167742999414287,0.0075733250317933,-0.0033546044617024,0.0087260181347654,-0.2002627463246794,0
2021-02-25,Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain,GSK,-0.0086505334232388,-0.044337364476916,0.0087260181347654,-0.0017422116728303,0.0002904124603764,-0.0077808486765815,-0.0167742999414287,-0.0223966542136088,0.2511418515183761,1
2021-02-25,Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses,GSK,-0.0086505334232388,-0.044337364476916,0.0087260181347654,-0.0017422116728303,0.0002904124603764,-0.0077808486765815,-0.0167742999414287,-0.0223966542136088,0.2511418515183761,1
2021-02-26,Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg,GSK,-0.0223966542136088,0.2511418515183761,-0.0086505334232388,0.0087260181347654,-0.0017422116728303,0.0002904124603764,-0.0077808486765815,0.0035702845541856,-0.2838170256195536,2
2021-03-02,"Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report",GSK,0.0106729968228362,0.0336895953229194,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0087260181347654,-0.0017422116728303,0.0044001859810469,0.115325474115838,2
2021-03-02,"People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC",GSK,0.0106729968228362,0.0336895953229194,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0087260181347654,-0.0017422116728303,0.0044001859810469,0.115325474115838,2
2021-03-02,European Officials Seek To Garner Support For AstraZeneca COVID-19 Shot: CNBC,GSK,0.0106729968228362,0.0336895953229194,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0087260181347654,-0.0017422116728303,0.0044001859810469,0.115325474115838,2
2021-03-02,"AstraZeneca, Pfizer/BioNtech Single Shot COVID-19 Jab 80% Effective At Preventing Hospitalizations In Elderly",GSK,0.0106729968228362,0.0336895953229194,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0087260181347654,-0.0017422116728303,0.0044001859810469,0.115325474115838,2
2021-03-02,Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May,GSK,0.0106729968228362,0.0336895953229194,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0087260181347654,-0.0017422116728303,0.0044001859810469,0.115325474115838,2
2021-03-03,EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters,GSK,0.0044001859810469,0.115325474115838,0.0106729968228362,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0087260181347654,0.0011681569678643,0.2309362322515213,2
2021-03-04,"Emergent BioSolutions Capable Of Manufacturing 1B COVID-19 Vaccine Doses Annually, CEO Says",GSK,0.0011681569678643,0.2309362322515213,0.0044001859810469,0.0106729968228362,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0183781789464214,-0.1698443554720187,0
2021-03-04,Novartis Lends Support To Manufacture CureVac's COVID-19 Shots,GSK,0.0011681569678643,0.2309362322515213,0.0044001859810469,0.0106729968228362,0.0035702845541856,-0.0223966542136088,-0.0086505334232388,0.0183781789464214,-0.1698443554720187,0
2021-03-05,"WHO, SII Warn Of Raw Materials Shortage For COVID-19 Shots, Cites US Law As 'Serious' Limit:' Bloomberg",GSK,0.0183781789464214,-0.1698443554720187,0.0011681569678643,0.0044001859810469,0.0106729968228362,0.0035702845541856,-0.0223966542136088,0.0017185162793458,0.0680323801253024,2
2021-03-09,"Why AnPac Bio-Medical, Surface Oncology, CorMedix Are Rallying Today",GSK,0.0037176619039696,-0.1571198327307574,0.0017185162793458,0.0183781789464214,0.0011681569678643,0.0044001859810469,0.0106729968228362,0.0142448774807364,-0.181739879414298,0
2021-03-09,Surface Oncology To Test SRF388 Plus Keytruda Combo In Solid Tumor Settings,GSK,0.0037176619039696,-0.1571198327307574,0.0017185162793458,0.0183781789464214,0.0011681569678643,0.0044001859810469,0.0106729968228362,0.0142448774807364,-0.181739879414298,0
2021-03-10,"Pfizer, BioNTech Predict Increase In Capacity To 3B COVID-19 Vaccine Shots In 2022: Bloomberg",GSK,0.0142448774807364,-0.181739879414298,0.0037176619039696,0.0017185162793458,0.0183781789464214,0.0011681569678643,0.0044001859810469,-0.0014045163203527,0.0256421052631579,2
2021-03-15,"Germany, France Join List Of Countries Suspending AZN's COVID-19 Vaccine; WHO Urges Not To Halt Vaccinations",GSK,0.0095665753956466,0.0259215706324453,-0.0002812042646137,-0.0014045163203527,0.0142448774807364,0.0037176619039696,0.0017185162793458,0.013099238327761,-0.1554204458619887,0
2021-03-17,"Pfizer/BioNTech COVID-19 Vaccination Could Protect Pregnant Women, Newborns, Study In Israel Suggests: Reuters",GSK,0.0,0.2077416309350537,0.013099238327761,0.0095665753956466,-0.0002812042646137,-0.0014045163203527,0.0142448774807364,0.0035763510637207,-0.2252133411504137,2
2021-03-18,"The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq",GSK,0.0035763510637207,-0.2252133411504137,0.0,0.013099238327761,0.0095665753956466,-0.0002812042646137,-0.0014045163203527,0.0041120209967737,-0.2191066736731476,2
2021-03-22,AstraZeneca's COVID-19 Shot Shows 79% Efficacy In US Trials,GSK,0.0010918809984399,-0.1392694678474334,0.0041120209967737,0.0035763510637207,0.0,0.013099238327761,0.0095665753956466,-0.0185436699042277,0.6768927666760485,1
2021-03-23,"Mastercard, SoftBank And Leading Companies Seek G7 To Create Global Tech Body: FT",GSK,-0.0185436699042277,0.6768927666760485,0.0010918809984399,0.0041120209967737,0.0035763510637207,0.0,0.013099238327761,-0.0033343575797039,0.0934877475662974,2
2021-03-29,White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments,GSK,0.000545231029962,-0.1324026120243188,0.0166344676945995,0.0055755436982682,-0.0033343575797039,-0.0185436699042277,0.0010918809984399,-0.0087214496564022,0.1644173371398909,1
2021-03-29,Glaxo To Fill About 60M Novavax COVID-19 Shots For Britain,GSK,0.000545231029962,-0.1324026120243188,0.0166344676945995,0.0055755436982682,-0.0033343575797039,-0.0185436699042277,0.0010918809984399,-0.0087214496564022,0.1644173371398909,1
2021-03-30,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",GSK,-0.0087214496564022,0.1644173371398909,0.000545231029962,0.0166344676945995,0.0055755436982682,-0.0033343575797039,-0.0185436699042277,-0.018696971389985,0.7179594338571269,1
2021-03-31,EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report,GSK,-0.018696971389985,0.7179594338571269,-0.0087214496564022,0.000545231029962,0.0166344676945995,0.0055755436982682,-0.0033343575797039,0.0036426044375716,0.2765767665136796,2
2021-03-31,Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents,GSK,-0.018696971389985,0.7179594338571269,-0.0087214496564022,0.000545231029962,0.0166344676945995,0.0055755436982682,-0.0033343575797039,0.0036426044375716,0.2765767665136796,2
2021-04-07,Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots,GSK,0.0011106043798068,-0.5451711513599071,-0.0016631359406202,0.0072586513314472,0.0036426044375716,-0.018696971389985,-0.0087214496564022,0.0110925635996255,0.1318439019206758,0
2021-04-08,"Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC",GSK,0.0110925635996255,0.1318439019206758,0.0011106043798068,-0.0016631359406202,0.0072586513314472,0.0036426044375716,-0.018696971389985,0.0052112485632771,-0.1072853588696427,0
2021-04-12,"South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Reports",GSK,-0.016098225252632,0.9159458393584856,0.0052112485632771,0.0110925635996255,0.0011106043798068,-0.0016631359406202,0.0072586513314472,-0.0005545702069301,-0.5471299383859591,2
2021-04-14,"UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots",GSK,0.0024971246812903,0.2968607963153749,-0.0005545702069301,-0.016098225252632,0.0052112485632771,0.0110925635996255,0.0011106043798068,0.0431774152429935,3.7130540433187695,0
2021-04-23,"The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs",GSK,0.0015926257864233,-0.0394624407674978,-0.014902234181932,0.0145889750254686,-0.007372261849654,0.0060927660765912,0.0015918702134347,0.00105965603111,-0.2759603720177921,2
2021-04-23,Oscar Telecast Sells Out Advertising Slots Despite Historically Low Award Show Ratings,GSK,0.0015926257864233,-0.0394624407674978,-0.014902234181932,0.0145889750254686,-0.007372261849654,0.0060927660765912,0.0015918702134347,0.00105965603111,-0.2759603720177921,2
2021-04-26,Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine,GSK,0.00105965603111,-0.2759603720177921,0.0015926257864233,-0.014902234181932,0.0145889750254686,-0.007372261849654,0.0060927660765912,-0.0013233616040763,-0.0307447432353187,2
2021-04-27,US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses,GSK,-0.0013233616040763,-0.0307447432353187,0.00105965603111,0.0015926257864233,-0.014902234181932,0.0145889750254686,-0.007372261849654,-0.0007950912892236,-0.1567847882454623,2
2021-04-28,Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran,GSK,-0.0007950912892236,-0.1567847882454623,-0.0013233616040763,0.00105965603111,0.0015926257864233,-0.014902234181932,0.0145889750254686,-0.0053051221555502,0.030750307503075,1
2021-04-29,Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters,GSK,-0.0053051221555502,0.030750307503075,-0.0007950912892236,-0.0013233616040763,0.00105965603111,0.0015926257864233,-0.014902234181932,-0.0042666440705934,0.1236077963404933,2
2021-04-30,"Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days",GSK,-0.0042666440705934,0.1236077963404933,-0.0053051221555502,-0.0007950912892236,-0.0013233616040763,0.00105965603111,0.0015926257864233,0.0088376885404533,0.2020827801870373,0
2021-05-03,Novavax Next In List To Start Testing Its COVID-19 Shot In Adolescents,GSK,0.0088376885404533,0.2020827801870373,-0.0042666440705934,-0.0053051221555502,-0.0007950912892236,-0.0013233616040763,0.00105965603111,-0.004512878797128,0.845191057010332,2
2021-05-06,"Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move",GSK,0.0034407623040924,0.316449263086566,0.0074666271235384,-0.004512878797128,0.0088376885404533,-0.0042666440705934,-0.0053051221555502,0.0116065983101674,-0.0335864110153133,0
2021-05-07,"The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs",GSK,0.0116065983101674,-0.0335864110153133,0.0034407623040924,0.0074666271235384,-0.004512878797128,0.0088376885404533,-0.0042666440705934,0.0046936415504368,0.1355193075898801,2
2021-05-10,FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children,GSK,0.0046936415504368,0.1355193075898801,0.0116065983101674,0.0034407623040924,0.0074666271235384,-0.004512878797128,0.0088376885404533,-0.0088243008136,0.3072322711148896,1
2021-05-26,FDA May Not Review New COVID-19 Vaccine Emergency Use Requests,GSK,0.0012934794148133,-0.0356169980931626,-0.000258671633162,-0.0046330311465063,-0.0046118755531281,0.0079279531479006,-0.0078362352081746,-0.0056834032392499,1.2251253442553494,1
2021-05-27,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-term Migraine Drug Data, Decision Day For Eton, 2 IPOs",GSK,-0.0056834032392499,1.2251253442553494,0.0012934794148133,-0.000258671633162,-0.0046330311465063,-0.0046118755531281,0.0079279531479006,0.0072746410904855,-0.3853379879403363,0
2021-06-01,"CureVac's COVID-19 Vaccine Is Safe, But Efficacy Not Yet Disclosed",GSK,-0.0108329947357518,-0.2377375051631557,0.0072746410904855,-0.0056834032392499,0.0012934794148133,-0.000258671633162,-0.0046330311465063,0.001042889811528,-0.0072814711958546,2
2021-06-14,"IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings",GSK,0.0084681752523727,0.0600598510682719,-0.0019884111709889,0.0171934987728092,0.018804645748649,0.0018063242318464,-0.0038558608119395,0.0019757446124437,-0.2030921743697479,2
2021-07-07,"COVID-19 Vaccine-Induced Blood Clots Probably Linked To Amino Acids, Study Shows: WSJ",GSK,0.0044932968141848,0.5581479192418624,-0.0086612251472467,0.0059747602959234,0.0087894525740406,-0.00325395701927,0.0017551422907478,-0.0067097961157663,0.0105774633920603,1
2021-07-28,"Earnings Scheduled For July 28, 2021",GSK,-0.0005062161252693,0.0780474883205701,0.0128140820119431,-0.0124018866494433,0.0071373129425729,-0.0022889301446717,0.0058839413669886,0.0151897893471182,0.2036768155114259,0
2021-08-02,GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine,GSK,0.0024913695071746,0.3614066925128543,0.0009975830880351,0.0151897893471182,-0.0005062161252693,0.0128140820119431,-0.0124018866494433,0.0099403020141177,-0.2830367782198614,0
2021-08-12,Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links,GSK,0.0036487774062163,-0.4241686477816286,0.0113159682531467,0.0017249677648554,0.0042069478641222,-0.0124631449749095,0.0103701493206171,0.0172079246068843,0.0607341822522879,0
2021-08-17,Stocks That Hit 52-Week Highs On Tuesday,GSK,0.0059409820818718,0.1883331243993147,0.0026210723841144,0.0172079246068843,0.0036487774062163,0.0113159682531467,0.0017249677648554,-0.0042523381379615,0.4352978409170827,2
2021-08-17,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",GSK,0.0059409820818718,0.1883331243993147,0.0026210723841144,0.0172079246068843,0.0036487774062163,0.0113159682531467,0.0017249677648554,-0.0042523381379615,0.4352978409170827,2
2021-08-18,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",GSK,-0.0042523381379615,0.4352978409170827,0.0059409820818718,0.0026210723841144,0.0172079246068843,0.0036487774062163,0.0113159682531467,0.0045651599293476,-0.2956611215914937,2
2021-08-19,"The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck",GSK,0.0045651599293476,-0.2956611215914937,-0.0042523381379615,0.0059409820818718,0.0026210723841144,0.0172079246068843,0.0036487774062163,0.0009567341085792,-0.3291940589237886,2
2021-08-24,Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial,GSK,-0.0110869572900145,-0.4023134585559194,-0.0086021821417932,0.0009567341085792,0.0045651599293476,-0.0042523381379615,0.0059409820818718,0.0019496455397489,-0.0725123436767939,2
2021-08-26,EU Says Without EMA Approval COVID-19 Boosters May Face Higher Legal Risks: Reuters,GSK,-0.0038920008647349,-0.2462405284631824,0.0019496455397489,-0.0110869572900145,-0.0086021821417932,0.0009567341085792,0.0045651599293476,-0.0031745627578642,1.3591091865140736,2
2021-09-02,Can Vaccine Help In Long Term COVID-19 Symptoms? UK Study Gives Encouraging Answer,GSK,0.0077839026535118,-0.2868975903614458,0.0090818976398223,-0.0041554482937005,0.0022048348115049,-0.0031745627578642,-0.0038920008647349,0.0043447438322559,0.329021471312918,2
2021-09-03,White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report,GSK,0.0043447438322559,0.329021471312918,0.0077839026535118,0.0090818976398223,-0.0041554482937005,0.0022048348115049,-0.0031745627578642,-0.0161018595784564,-0.0511487783883997,1
2021-09-28,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",GSK,-0.0116881718223251,0.2093672675857194,0.0028652194652438,-0.0241483893584828,0.0015274834515712,0.0051176337673988,0.0059203893150554,0.0073588254310115,0.1008096337649431,0
2021-09-30,"GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact",GSK,-0.003130789271731,-0.2919122723169242,0.0073588254310115,-0.0116881718223251,0.0028652194652438,-0.0241483893584828,0.0015274834515712,-0.0020936413359267,1.1326308684565771,2
2021-09-30,"The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug",GSK,-0.003130789271731,-0.2919122723169242,0.0073588254310115,-0.0116881718223251,0.0028652194652438,-0.0241483893584828,0.0015274834515712,-0.0020936413359267,1.1326308684565771,2
2021-10-04,Tesla and Merck Give Investors Some Hope,GSK,0.0073431719417853,-0.2263112549012712,-0.0020936413359267,-0.003130789271731,0.0073588254310115,-0.0116881718223251,0.0028652194652438,-0.004946573653663,-0.4612290350438616,2
2021-10-12,Winners and Losers of Rising Energy Prices,GSK,0.0104602067032364,1.1214067451335443,-0.0121415951960554,0.0012934395842449,0.0138997280599451,-0.0023547169682635,-0.004946573653663,0.0041407904595378,-0.3120073620613771,2
2021-10-12,"The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology",GSK,0.0104602067032364,1.1214067451335443,-0.0121415951960554,0.0012934395842449,0.0138997280599451,-0.0023547169682635,-0.004946573653663,0.0041407904595378,-0.3120073620613771,2
2021-10-26,"The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children",GSK,0.009294058354667,0.145654834761322,0.0010060146835335,0.0055625716188563,0.0022807218005562,0.007403795732102,0.0134537961314711,0.0059730753421081,0.5358611514271892,0
2021-10-27,"Earnings Scheduled For October 27, 2021",GSK,0.0059730753421081,0.5358611514271892,0.009294058354667,0.0010060146835335,0.0055625716188563,0.0022807218005562,0.007403795732102,0.0420583363790234,0.1882112060479583,0
2021-10-28,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",GSK,0.0420583363790234,0.1882112060479583,0.0059730753421081,0.009294058354667,0.0010060146835335,0.0055625716188563,0.0022807218005562,0.0049857657302219,-0.4234682042615236,2
2021-11-29,3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries,GSK,0.0082885303780708,0.5349118316268486,-0.0139421319951094,0.0,0.0075077842950834,-0.0072132577223895,0.0021685148319823,-0.0058027350220513,-0.0805114189095288,1
2021-12-02,"The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance",GSK,0.0024172703845966,0.1722859845095985,0.0060798195464477,-0.0058027350220513,0.0082885303780708,-0.0139421319951094,0.0,-0.0053051126086229,-0.1090032925579468,1
2021-12-02,Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant,GSK,0.0024172703845966,0.1722859845095985,0.0060798195464477,-0.0058027350220513,0.0082885303780708,-0.0139421319951094,0.0,-0.0053051126086229,-0.1090032925579468,1
2021-12-07,"The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Dar",GSK,0.0148467637800464,0.7791167253578006,0.0123636695579563,-0.0053051126086229,0.0024172703845966,0.0060798195464477,-0.0058027350220513,0.0070787958870612,-0.3529753581870017,0
2021-12-07,"Cramer Gives His Opinion On GlaxoSmithKline, Asana And More",GSK,0.0148467637800464,0.7791167253578006,0.0123636695579563,-0.0053051126086229,0.0024172703845966,0.0060798195464477,-0.0058027350220513,0.0070787958870612,-0.3529753581870017,0
2021-12-15,"Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back",GSK,0.0177156045127921,0.6823281406316992,-0.0048712119678026,-0.0013898139145962,0.0086448291332208,0.0028116343542525,0.0070787958870612,0.0036646062029526,0.2543060422639907,2
2021-12-15,"The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO",GSK,0.0177156045127921,0.6823281406316992,-0.0048712119678026,-0.0013898139145962,0.0086448291332208,0.0028116343542525,0.0070787958870612,0.0036646062029526,0.2543060422639907,2
2021-12-21,"The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail",GSK,0.0069671023429618,-0.0343632054770473,-0.0009281718738347,-0.016430837862288,0.0036646062029526,0.0177156045127921,-0.0048712119678026,0.0094556938372238,-0.2874608007998909,0
2022-02-09,"Earnings Scheduled For February 9, 2022",GSK,-0.0212295527516099,-0.4361938187988572,0.0051121583634368,0.0042411581998702,-0.0026714280519917,-0.0170678670606397,0.0112857119075286,0.0040668507624925,0.9530289389067524,2
2022-02-10,Why Are Seagen Shares Sinking Today?,GSK,0.0040668507624925,0.9530289389067524,-0.0212295527516099,0.0051121583634368,0.0042411581998702,-0.0026714280519917,-0.0170678670606397,-0.0031502843131592,-0.5850982561508877,2
2022-02-25,Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption,GSK,0.03617384460733,-0.3178826538569512,-0.0307779862956634,0.0100727344381161,-0.0081319848974886,-0.0064636495168188,-0.0016131665692993,-0.0192127629510849,0.2654335101518199,1
2022-03-02,36 Stocks To Watch After Biden's First State of The Union Address,GSK,0.0115522758110262,-0.0517037768664248,-0.0074056652875328,-0.0192127629510849,0.03617384460733,-0.0307779862956634,0.0100727344381161,-0.0137995794147957,0.7011434393750708,1
2022-03-16,"WHO Foundation Warns Global Economy To Lose ""Trillions Of Dollars"" On COVID-19 Vaccine Inequality: CNBC",GSK,0.0095922513503781,0.1451071276545428,0.0228109770204871,0.0051773665706131,-0.0066128584934902,-0.0123366137425774,0.0340170818790503,0.0225653818476203,-0.0590021064805253,0
2022-03-21,Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC,GSK,-0.0041841779291733,0.1345743277280686,-0.0006967389577466,0.0225653818476203,0.0095922513503781,0.0228109770204871,0.0051773665706131,0.0091035794313265,0.2118104742372666,0
2022-03-24,Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC,GSK,0.009088728431803,0.0966826636774442,-0.0074021910969912,0.0091035794313265,-0.0041841779291733,-0.0006967389577466,0.0225653818476203,-0.0004618718556498,2.0708467754815216,2
2022-03-28,FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant,GSK,0.00207947537014,-0.6864019804657839,-0.0004618718556498,0.009088728431803,-0.0074021910969912,0.0091035794313265,-0.0041841779291733,-0.0018444140947794,0.5572987495439319,2
2022-03-29,FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV,GSK,-0.0018444140947794,0.5572987495439319,0.00207947537014,-0.0004618718556498,0.009088728431803,-0.0074021910969912,0.0091035794313265,0.0094708331677086,0.0978040936295285,0
2022-03-29,Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness,GSK,-0.0018444140947794,0.5572987495439319,0.00207947537014,-0.0004618718556498,0.009088728431803,-0.0074021910969912,0.0091035794313265,0.0094708331677086,0.0978040936295285,0
2022-03-30,"Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ",GSK,0.0094708331677086,0.0978040936295285,-0.0018444140947794,0.00207947537014,-0.0004618718556498,0.009088728431803,-0.0074021910969912,-0.00320350930708,-0.396212870806899,2
2022-03-30,"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",GSK,0.0094708331677086,0.0978040936295285,-0.0018444140947794,0.00207947537014,-0.0004618718556498,0.009088728431803,-0.0074021910969912,-0.00320350930708,-0.396212870806899,2
2022-04-18,"As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ",GSK,-0.0025906360981022,-0.3484259879437374,-0.0113126707887717,0.0068772979039612,0.0010756803849041,-0.0034304540121256,0.0088686216525897,-0.0067099809701074,0.3098684210526317,1
2022-04-22,"Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ",GSK,-0.0179469634613941,-0.2084838991046157,-0.0032722689135231,-0.0010895966202891,-0.0067099809701074,-0.0025906360981022,-0.0113126707887717,0.0060173625789448,-0.044192061171708,0
2022-04-27,"Earnings Scheduled For April 27, 2022",GSK,0.0236540153982482,0.2618640309193436,-0.0166150644597921,0.0060173625789448,-0.0179469634613941,-0.0032722689135231,-0.0010895966202891,0.0066021483158866,-0.1451596706165896,0
2022-04-27,"The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis",GSK,0.0236540153982482,0.2618640309193436,-0.0166150644597921,0.0060173625789448,-0.0179469634613941,-0.0032722689135231,-0.0010895966202891,0.0066021483158866,-0.1451596706165896,0
2022-05-31,Unilever Jumps After Nelson Peltz Joins Board,GSK,-0.0036314779627016,0.3829683528879295,-0.0081043186759525,-0.0122304305152822,-0.0006666188283678,0.0055865131261789,0.0051663179990246,-0.0195900335479223,-0.2289857261536138,1
2022-05-31,Unilever To Add This Activist Investor To Board - What's The Catch?,GSK,-0.0036314779627016,0.3829683528879295,-0.0081043186759525,-0.0122304305152822,-0.0006666188283678,0.0055865131261789,0.0051663179990246,-0.0195900335479223,-0.2289857261536138,1
2022-05-31,"Morning Brief: Top Financial Stories Dominating on Tuesday, May 31",GSK,-0.0036314779627016,0.3829683528879295,-0.0081043186759525,-0.0122304305152822,-0.0006666188283678,0.0055865131261789,0.0051663179990246,-0.0195900335479223,-0.2289857261536138,1
2022-06-01,"Morning Brief: Top Financial Stories Dominating on Wednesday, June 1",GSK,-0.0195900335479223,-0.2289857261536138,-0.0036314779627016,-0.0081043186759525,-0.0122304305152822,-0.0006666188283678,0.0055865131261789,0.0081319654193168,-0.2981846083521076,0
2022-06-01,Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off,GSK,-0.0195900335479223,-0.2289857261536138,-0.0036314779627016,-0.0081043186759525,-0.0122304305152822,-0.0006666188283678,0.0055865131261789,0.0081319654193168,-0.2981846083521076,0
2022-06-06,"Morning Brief: Top Financial Stories Dominating on Monday, June 6",GSK,0.0021068666784451,-0.2389614552448112,-0.0154413860218695,0.0081319654193168,-0.0195900335479223,-0.0036314779627016,-0.0081043186759525,0.033636972758813,2.581315152153312,0
2022-06-10,"Morning Brief: Top Financial Stories Dominating on Friday, June 10",GSK,0.0176579742205693,0.8422984562607203,-0.0262443583866053,-0.0011299808641878,0.033636972758813,0.0021068666784451,-0.0154413860218695,-0.0296803609914639,-0.0422788298605292,1
2022-06-13,"Morning Brief: Top Financial Stories Dominating on Monday, June 13",GSK,-0.0296803609914639,-0.0422788298605292,0.0176579742205693,-0.0262443583866053,-0.0011299808641878,0.033636972758813,0.0021068666784451,-0.0296470600864803,-0.2225441112137267,1
2022-06-24,"Benzinga Before The Bell: Gun Safety Bill. Bill Gates North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24",GSK,0.0219882595449274,-0.3779140522514264,0.0185845858003137,0.004788189628166,0.0121153576925792,-0.0088856786734266,-0.0073898435709092,0.0002289289285954,-0.0860518292682926,2
2022-06-27,"The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies",GSK,0.0002289289285954,-0.0860518292682926,0.0219882595449274,0.0185845858003137,0.004788189628166,0.0121153576925792,-0.0088856786734266,-0.0080091485811004,0.075612264754121,1
2022-07-18,"Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18",GSK,-0.0203636045346827,-0.4928759435296165,0.0256090357911207,-0.0171064424895291,-0.0125481851353217,-0.0196357847125976,-0.0016532262109879,0.0866122649440006,-0.8885814781452408,0
2022-07-19,"Benzinga Before The Bell: Musk's Twitter Lawsuit, Uber Penalized For Overcharging People With Disabilities, Johnson & Johnson Cuts Outlook And Other Top Financial Stories Tuesday, July 19",GSK,0.0866122649440006,-0.8885814781452408,-0.0203636045346827,0.0256090357911207,-0.0171064424895291,-0.0125481851353217,-0.0196357847125976,-0.0526077669061109,0.1890279114533204,1
2022-07-27,"Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy",GSK,0.0239887475248079,-0.0688485218153746,0.0085388460588695,-0.003074039972843,0.0073845636676543,0.0091346537939172,-0.0526077669061109,-0.0140100634916677,0.2950195492415712,1
2022-07-27,"Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2",GSK,0.0239887475248079,-0.0688485218153746,0.0085388460588695,-0.003074039972843,0.0073845636676543,0.0091346537939172,-0.0526077669061109,-0.0140100634916677,0.2950195492415712,1
2022-07-27,IDEAYA's Cancer Candidate Shows Early Tumor Modulation,GSK,0.0239887475248079,-0.0688485218153746,0.0085388460588695,-0.003074039972843,0.0073845636676543,0.0091346537939172,-0.0526077669061109,-0.0140100634916677,0.2950195492415712,1
2022-07-28,"Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate",GSK,-0.0140100634916677,0.2950195492415712,0.0239887475248079,0.0085388460588695,-0.003074039972843,0.0073845636676543,0.0091346537939172,-0.0177033099615657,-0.2060762214880735,1
2022-08-10,"Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial",GSK,-0.0432175670510694,1.4719982326300671,-0.0069462217387439,-0.0064087332344674,-0.0007388632375481,-0.0053895775421421,-0.008742148222158,-0.0671017736488654,1.2591268600026813,1
2022-08-11,Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke,GSK,-0.0671017736488654,1.2591268600026813,-0.0432175670510694,-0.0069462217387439,-0.0064087332344674,-0.0007388632375481,-0.0053895775421421,0.0083962534051471,-0.6617876851870166,0
2022-08-15,Landmark Drug Pricing Reform Bill Passes Congress House,GSK,-0.0299749451023526,0.2868672353437544,0.0083962534051471,-0.0671017736488654,-0.0432175670510694,-0.0069462217387439,-0.0064087332344674,0.008869702354004,-0.2412143167845016,0
2022-08-24,Stocks That Hit 52-Week Lows On Wednesday,GSK,-0.0059295744428435,-0.0451844414083718,-0.0093979747894255,-0.0002936575562416,-0.0055472935243463,-0.0017198012679128,-0.0158818103026131,0.0059649440224722,0.1021790849222494,0
2022-08-29,Stocks That Hit 52-Week Lows On Monday,GSK,-0.0024101385636347,-0.5357492414603112,-0.0160096549995555,0.0059649440224722,-0.0059295744428435,-0.0093979747894255,-0.0002936575562416,-0.004530426725489,0.0526801243872872,2
2022-08-30,Stocks That Hit 52-Week Lows On Tuesday,GSK,-0.004530426725489,0.0526801243872872,-0.0024101385636347,-0.0160096549995555,0.0059649440224722,-0.0059295744428435,-0.0093979747894255,-0.0145631549066052,0.074427337589185,1
2022-08-30,"With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report",GSK,-0.004530426725489,0.0526801243872872,-0.0024101385636347,-0.0160096549995555,0.0059649440224722,-0.0059295744428435,-0.0093979747894255,-0.0145631549066052,0.074427337589185,1
2022-09-01,Novartis Appoints Merck Executive As Research Head,GSK,-0.0243226219091391,1.887110303369216,-0.0145631549066052,-0.004530426725489,-0.0024101385636347,-0.0160096549995555,0.0059649440224722,0.0050489280568861,-0.341976773277163,0
2022-09-02,"White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox",GSK,0.0050489280568861,-0.341976773277163,-0.0243226219091391,-0.0145631549066052,-0.004530426725489,-0.0024101385636347,-0.0160096549995555,-0.0119310265969678,-0.3114736002943521,1
2022-09-22,"Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More..",GSK,0.0080618340424254,0.2000731703437415,-0.0236143143067497,-0.0094217333533289,-0.0016218022697915,-0.0061250382595503,-0.0057692498248952,-0.0216594536303139,0.2030353237457751,1
2022-09-22,"US Stocks Could Remain Jittery Thursday Over Fed Rate Hike As S&P 500, Nasdaq Futures See Volatility  McDonald's In Focus",GSK,0.0080618340424254,0.2000731703437415,-0.0236143143067497,-0.0094217333533289,-0.0016218022697915,-0.0061250382595503,-0.0057692498248952,-0.0216594536303139,0.2030353237457751,1
2022-09-26,"iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26",GSK,-0.0183923652488595,0.3583618875532981,-0.0216594536303139,0.0080618340424254,-0.0236143143067497,-0.0094217333533289,-0.0016218022697915,-0.0055517185614404,-0.4596598236663449,1
2022-10-04,DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round,GSK,0.0152065981197648,0.2849697048667665,0.0278626850158356,0.0023842040800809,-0.0033944443315089,0.0279134931985796,-0.0055517185614404,-0.0097687744157628,-0.264336054352786,1
2022-10-05,AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial,GSK,-0.0097687744157628,-0.264336054352786,0.0152065981197648,0.0278626850158356,0.0023842040800809,-0.0033944443315089,0.0279134931985796,-0.0134823879904942,0.0737792480788448,1
2022-10-13,GSK Touts 'Exceptional Results' From RSV Vaccine Candidate In Older Adults,GSK,0.0092195266863175,0.0233068682633741,-0.00197174484147,0.0079496783147134,0.0026569333600765,0.0036666787867405,-0.0134823879904942,0.0019575922262691,-0.1042503427695782,2
2022-10-13,"US Stocks Show Cautious Optimism As S&P 500, Dow Futures Surge Ahead Of Key CPI Data  Trump's SPAC Partner, Applied Materials And Chip Stocks In Focus Today",GSK,0.0092195266863175,0.0233068682633741,-0.00197174484147,0.0079496783147134,0.0026569333600765,0.0036666787867405,-0.0134823879904942,0.0019575922262691,-0.1042503427695782,2
2022-10-13,"Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13",GSK,0.0092195266863175,0.0233068682633741,-0.00197174484147,0.0079496783147134,0.0026569333600765,0.0036666787867405,-0.0134823879904942,0.0019575922262691,-0.1042503427695782,2
2022-10-20,Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny,GSK,-0.0079846962111087,-0.3077415526825308,0.0019199441108792,-0.0015973873268554,0.0192119842219562,0.0019575922262691,0.0092195266863175,0.0260786457882082,0.6193752114582158,0
2022-11-02,"Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02",GSK,-0.0101613047566249,-0.1162981369593461,0.008742928772107,-0.0030058377492825,0.016809287466484,0.0009177744297219,0.0139576809039851,-0.0084541340741454,-0.217973422401119,1
2022-11-16,"Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says",GSK,0.0192009932380878,-0.0334808017914687,-0.0076827580750733,0.0303989646302014,-0.0564684919404255,0.0323874639773773,0.0062072241762745,-9.205014097612985e-05,-0.3352546714888487,2
2022-11-25,European Official Says COVID-19 Booster Uptake Disappointing In The Region,GSK,0.0089048282194437,-0.5236992211251701,-0.0047267326403734,0.0122606994919323,0.0167223367500419,0.0092052706216023,-9.205014097612985e-05,-0.0067667477573534,3.346079027355623,1
2022-12-07,GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial,GSK,-0.0274261408388334,-0.5396281005168883,0.0784982333258592,-0.0053747649159995,0.0091350205913971,0.0127204302272498,0.0066937687389712,-0.0075922897683027,-0.394958161211736,1
2022-12-07,"Meta Criticized For Providing Extra Protection To Certain Users, Twitter HQ Bedrooms Under Regulatory Scrutiny, Juul Settles Over 5,000 Lawsuits: Top Stories Wednesday, Dec. 07",GSK,-0.0274261408388334,-0.5396281005168883,0.0784982333258592,-0.0053747649159995,0.0091350205913971,0.0127204302272498,0.0066937687389712,-0.0075922897683027,-0.394958161211736,1
2023-01-18,Jim Cramer Says This Stock Up 23% In A Month Is 'A Great Speculative Buy',GSK,-0.0104049956455866,0.3217277415482005,0.0050876162476281,0.0065434356148725,0.0138448126164731,-0.0020150222033806,0.0060817194735369,0.0119352003756119,-0.3637489677952106,0
2023-01-18,Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,GSK,-0.0104049956455866,0.3217277415482005,0.0050876162476281,0.0065434356148725,0.0138448126164731,-0.0020150222033806,0.0060817194735369,0.0119352003756119,-0.3637489677952106,0
2023-01-31,"February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More",GSK,0.0039863299511322,0.2312185042275496,-0.0050991468036476,-0.0011319700288948,0.0048337163680229,0.0135446025699395,-0.0186651441402574,0.0065231317717182,-0.0100011987738256,0
2023-02-15,JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals,GSK,-0.0135885069143539,0.8898999255344267,-0.0046921876033126,0.0108816345136393,-0.0161953793274931,0.0030285790936743,0.0041471335872567,,,2
2023-02-15,EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue,GSK,-0.0135885069143539,0.8898999255344267,-0.0046921876033126,0.0108816345136393,-0.0161953793274931,0.0030285790936743,0.0041471335872567,,,2
